preferaob plus dha prenatal/postnatal multivitamin/multimineral
meda pharmaceuticals - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41) - cholecalciferol 400 [iu]
selontra soft bait rodenticide
basf australia ltd. - cholecalciferol - bait - cholecalciferol vitamin-d3 active 0.75 g/kg - vertebrate poison
feracol
aotea ip holdings limited - cholecalciferol - cholecalciferol 8.07 g/kg - vertebrate toxic agent
pestoff decal possum bait
animal control products limited trading as orillion - cholecalciferol - cholecalciferol 8 g/kg - vertebrate toxic agent
d3 rat one feed bait
aotea ip holdings limited - cholecalciferol - cholecalciferol 4 g/kg - vertebrate toxic agent
zatean-pn plus- levomefolate calcium, folic acid, ascorbic acid, cholecalciferol, .alpha.-tocopherol, pyridoxine, cyanocobalamin
trigen laboratories, llc - levomefolic acid (unii: 8s95dh25xc) (levomefolic acid - unii:8s95dh25xc), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u - levomefolate calcium 600 ug - this product is contraindicated in patients with a known hypersensitivity to any of the ingredients including soy or fish oil.
nestabs dha prenatal multi-vitamin/mineral supplement with dha/epa (sodium ascorbate, cholecalciferol, di-alpha-tocopheryl aceta
womens choice pharmaceuticals llc - thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium formate (unii: np3jd65npy) (calcium cation - unii:2m83c4r6zb), calcium carbonate (unii: h - ascorbic acid 120 mg - i ndications and usage: nestabs dha is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. nestabs dha is also beneficial in improving the nutritional status of women prior to conception. c ontraindications: this product is contraindicated in patients with a known hypersensitivity to any of the ingredients .
rulavite dha levomefolate calcium folic acid ascorbic cholecalciferol .alpha.-tocopherol d- pyridoxine hydrochloride cyanocobala
method pharmaceuticals, llc - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc) - levomefolate calcium 600 ug
revesta capsule
sterling knight pharmaceuticals,llc - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - cholecalciferol 5750 [iu] - revesta is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels, vitamin d deficiency or are in need of vitamin d supplementation and other nutritional supplementation. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients. revesta is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
ciferex capsule
adler-stern pharmaceuticals, llc - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - cholecalciferol 3775 [iu] - ciferex is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels, vitamin d deficiency or are in need of vitamin d supplementation and other nutritional supplementation. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients. ciferex is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.